2-methacryloyloxyethyl phosphorylcholine,
2-MOEP,
67881-98-5,
2-Methacryloyloxyethyl phosphorylcholine,
2-(Methacryloyloxy)ethyl 2-(Trimethylammonio)ethyl Phosphate,
UNII-59RU860S8D,
59RU860S8D,
2-(Methacryloyloxy)ethyl (2-(trimethylammonio)ethyl) phosphate,
2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate,
2-Moep,
Creatinol O-phosphate Magnesium,
AC1L2UPZ,
ACMC-209o1b,
EC 417-560-0,
AC1Q22JS,
SCHEMBL35785,
3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium, 4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,
67881-99-6,
2-(Methacryloyloxyethyl)-2'-((trimethylammonium)ethyl)phosphate,
BCP07653,
ANW-35421,
MFCD11112180,
AKOS015856763,
RL04593,
KS-0000112Y,
AN-38255,
SC-66891,
TC-124166,
FT-0655547,
M2005,
Z3271,
A835920,
I14-6986,
J-506449,
2-(2-Methylprop-2-enoyloxy)ethyl 2-trimethylazaniumylethyl phosphate,
2-(2-methyl-1-oxoprop-2-enoxy)ethyl 2-(trimethylammonio)ethyl phosphate,
2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylammonio)ethyl phosphate,
2-Methacryloyloxyethyl phosphorylcholine, contains <=100 ppm MEHQ as inhibitor, 97%,
3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide,
Ethanaminium, 2-((hydroxy(2-((2-methyl-1-oxo-2-propenyl)oxy)ethoxy)phosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt,
C11H22NO6P,
2-methacryloyloxyethylphosphorylcholine,
C11-H22-N-O6-P,
AR-1C9424,
CID128934,
(C11-H22-N-O6-P)x-,
2-(Methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, 96% - 1G 1g,
Phosphoric Acid 2-(Methacryloyloxy)ethyl 2-(Trimethylammonio)ethyl Ester,
68512-16-3,
MPC,